515 related articles for article (PubMed ID: 32126223)
21. Effect of inhibition of fatty acid amide hydrolase on MPTP-induced dopaminergic neuronal damage.
Viveros-Paredes JM; Gonzalez-Castañeda RE; Escalante-Castañeda A; Tejeda-Martínez AR; Castañeda-Achutiguí F; Flores-Soto ME
Neurologia (Engl Ed); 2019 Apr; 34(3):143-152. PubMed ID: 28104279
[TBL] [Abstract][Full Text] [Related]
22. The parthenolide derivative ACT001 synergizes with low doses of L-DOPA to improve MPTP-induced Parkinson's disease in mice.
Liu Q; Zhang S; Zhu D; Tang X; Che Y; Feng X
Behav Brain Res; 2020 Feb; 379():112337. PubMed ID: 31697983
[TBL] [Abstract][Full Text] [Related]
23. Apelin-36 mitigates MPTP/MPP
Zhu J; Dou S; Wang C; Jiang Y; Wang C; Cheng B
Brain Res; 2019 Oct; 1721():146334. PubMed ID: 31306618
[TBL] [Abstract][Full Text] [Related]
24. Naringenin Decreases α-Synuclein Expression and Neuroinflammation in MPTP-Induced Parkinson's Disease Model in Mice.
Mani S; Sekar S; Barathidasan R; Manivasagam T; Thenmozhi AJ; Sevanan M; Chidambaram SB; Essa MM; Guillemin GJ; Sakharkar MK
Neurotox Res; 2018 Apr; 33(3):656-670. PubMed ID: 29427283
[TBL] [Abstract][Full Text] [Related]
25. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
Shin JY; Park HJ; Ahn YH; Lee PH
J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic effects of paeonol on methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid-induced Parkinson's disease in mice.
Shi X; Chen YH; Liu H; Qu HD
Mol Med Rep; 2016 Sep; 14(3):2397-404. PubMed ID: 27484986
[TBL] [Abstract][Full Text] [Related]
27. Squamosamide derivative FLZ protected tyrosine hydroxylase function in a chronic MPTP/probenecid mouse model of Parkinson's disease.
Bao XQ; Wu LY; Wang XL; Sun H; Zhang D
Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):549-56. PubMed ID: 25678053
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of natural resistance-associated macrophage protein-1 (Nramp1) is associated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)/1-methyl-4-phenylpyridinium (MPP
Wu KC; Liou HH; Lee CY; Lin CJ
Neuropathol Appl Neurobiol; 2019 Feb; 45(2):157-173. PubMed ID: 29679389
[TBL] [Abstract][Full Text] [Related]
29. Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson's Disease.
Klemann CJHM; Xicoy H; Poelmans G; Bloem BR; Martens GJM; Visser JE
Mol Neurobiol; 2018 Jul; 55(7):5639-5657. PubMed ID: 29019056
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
31. Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2/MyD88/NF-κB signaling pathway.
Koo JH; Jang YC; Hwang DJ; Um HS; Lee NH; Jung JH; Cho JY
Neuroscience; 2017 Jul; 356():102-113. PubMed ID: 28527958
[TBL] [Abstract][Full Text] [Related]
32. Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factor.
Komnig D; Dagli TC; Habib P; Zeyen T; Schulz JB; Falkenburger BH
J Neurochem; 2018 Dec; 147(5):678-691. PubMed ID: 30152864
[TBL] [Abstract][Full Text] [Related]
33. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
[TBL] [Abstract][Full Text] [Related]
35. Fatty Acid-Binding Protein 3 is Critical for α-Synuclein Uptake and MPP
Kawahata I; Bousset L; Melki R; Fukunaga K
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661838
[TBL] [Abstract][Full Text] [Related]
36. Gynostemma pentaphyllum Ethanolic Extract Protects Against Memory Deficits in an MPTP-Lesioned Mouse Model of Parkinson's Disease Treated with L-DOPA.
Kim KS; Zhao TT; Shin KS; Park HJ; Cho YJ; Lee KE; Kim SH; Lee MK
J Med Food; 2017 Jan; 20(1):11-18. PubMed ID: 28005447
[TBL] [Abstract][Full Text] [Related]
37. Pain perception in acute model mice of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Park J; Lim CS; Seo H; Park CA; Zhuo M; Kaang BK; Lee K
Mol Pain; 2015 May; 11():28. PubMed ID: 25981600
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Matheus FC; Aguiar AS; Castro AA; Villarinho JG; Ferreira J; Figueiredo CP; Walz R; Santos AR; Tasca CI; Prediger RD
Behav Brain Res; 2012 Dec; 235(2):263-72. PubMed ID: 22921927
[TBL] [Abstract][Full Text] [Related]
39. Suppression of neuroinflammation and α-synuclein oligomerization by rotarod walking exercise in subacute MPTP model of Parkinson's disease.
Leem YH; Park JS; Park JE; Kim DY; Kim HS
Neurochem Int; 2023 May; 165():105519. PubMed ID: 36931345
[TBL] [Abstract][Full Text] [Related]
40. Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease.
Zhang QS; Heng Y; Mou Z; Huang JY; Yuan YH; Chen NH
Acta Pharmacol Sin; 2017 Oct; 38(10):1317-1328. PubMed ID: 28649132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
